Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded.

Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further ...

Roche earned $5.8 billion from the sale of risdiplam in the 2021-2024 period, about 115 times the calculated cost.

Roche moves to mitigate US tariff impact amid discussions with global governments By Angus Liu Apr 24, 2025 10:48am Roche Thomas Schinecker pharma CEO tariffs ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...

Basel, Switzerland-based Roche currently maintains 13 manufacturing and 15 R&D sites in the U.S. across its pharmaceutical and diagnostics divisions. These sites employ more than 25,000.

ZURICH (Reuters) - Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 new jobs, in the latest massive investment by ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.

Roche and the pharmaceutical industry as a whole are grappling with the effects of President Donald Trump’s tariffs on imports to the U.S. Drugmaker Novartis’ also plans to spend $23 billion ...

Roche doesn’t just want to win Western States and set a course record; he also wants to do it in the way he wants to, with his own mix of self-experimentation and science. It’s a recipe that ...

Investors largely appeared to share Steensberg’s optimism. Shares of Zealand traded on Nasdaq Copenhagen surged 38% from DKK 488.80 ($71.54) to an even DKK 674 ($98.38), while Roche shares ...